Siemens Healthineers AG completed the acquisition of 100 percent of Corindus Vascular Robotics, Inc. effective October 29, 2019. Prior to the closing of the acquisition, Corindus held a shareholders' meeting on October 25, 2019, at which 87.5 percent of their stockholders approved the acquisition.

InterSystems, a global leader in information technology platforms for health, business, and government applications, announced its tremendous performance in the new KLAS® Research report, "Interoperability Platforms 2019." InterSystems customers provided highly positive feedback for the company's tools and technology across all report categories, including use cases, user experience, ease of maintenance and point-of-care.

A pioneering NHS trust has been recognised at the 2019 HTN Awards for its innovative work using InterSystems technology to help enhance care for hundreds of thousands of patients. North Tees and Hartlepool NHS Foundation Trust was selected by an independent judging panel as the winner of two national awards - Health Tech Team of the Year and, in collaboration with InterSystems, Best use of ePMA, or electronic prescribing and medicines administration.

More than 300,000 people suffering with mental health disorders such as anxiety and depression have now been treated through innovative digital therapy programmes developed as a result of a partnership between Berkshire Healthcare NHS Foundation Trust and SilverCloud Health, the world's leading digital mental health company.

Royal Philips (NYSE:PHG, AEX:PHIA), a global leader in health technology, and German Klinikum Stuttgart hospital, the largest provider in the region, announced they have signed a comprehensive 10-year innovation partnership agreement.

Siemens Healthineers has launched the ACUSON Redwood, a new ultrasound system built on the company's new platform architecture and features advanced applications for greater clinical confidence, AI-powered tools for smart workflows and has shared services cardiology features used by different hospital departments.

Bayer launched LifeHub UK to accelerate and optimize disease detection and data-driven drug discovery by developing artificial-intelligence-enabled imaging solutions. The new hub is the seventh pillar of Bayer's global network of LifeHubs designed to accelerate the co-exploration and development of pioneering solutions to solve global challenges in health and nutrition.